S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33

Compare Stocks

Date Range: 

 Hill-RomPenumbraGlobus MedicalTandem Diabetes CareShockWave Medical
SymbolNYSE:HRCNYSE:PENNYSE:GMEDNASDAQ:TNDMNASDAQ:SWAV
Price Information
Current Price$150.00$278.73$81.22$123.77$222.56
50-Day Moving Average$138.20$269.40$80.55$112.36$198.76
52-Week Low$80.76$163.49$48.00$76.19$66.09
52-Week High$152.37$320.00$84.23$130.73$237.76
MarketRank™
Overall Score2.12.42.32.21.9
Analysis Score1.12.52.42.31.2
Community Score4.45.04.84.44.3
Dividend Score1.70.00.00.00.0
Ownership Score2.52.53.32.53.3
Earnings & Valuation Score0.61.91.31.90.6
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyHold
Consensus Price Target$137.67$324.86$82.18$130.13$203.00
% Upside from Price Target-8.22% downside16.55% upside1.18% upside5.13% upside-8.79% downside
Trade Information
Market Cap$9.87 billion$10.20 billion$8.19 billion$7.80 billion$7.82 billion
Beta0.60.281.080.281.28
Average Volume616,991303,882456,148714,452387,127
Sales & Book Value
Annual Revenue$2.88 billion$560.41 million$789.04 million$498.83 million$67.79 million
Price / Sales3.4318.1910.3915.64115.40
Cashflow$9.89 per share$0.53 per share$2.08 per shareN/AN/A
Price / Cash15.16528.8038.98N/AN/A
Book Value$25.92 per share$17.56 per share$15.11 per share$6.01 per share$6.59 per share
Price / Book5.7915.875.3820.5933.77
Profitability
Net Income$223 million$-15,700,000.00$102.29 million$-34,380,000.00$-65,700,000.00
EPS$5.53$0.11$1.44($0.39)($1.99)
Trailing P/E Ratio42.25648.2145.122,475.90N/A
Forward P/E Ratio23.40167.9137.43158.68167.34
P/E GrowthN/A13.674.27N/AN/A
Net Margins8.12%2.37%19.83%1.08%-40.60%
Return on Equity (ROE)21.74%5.52%14.10%3.68%-24.14%
Return on Assets (ROA)8.41%4.21%12.72%1.69%-19.24%
Dividend
Annual Payout$0.96N/AN/AN/AN/A
Dividend Yield0.64%N/AN/AN/AN/A
Three-Year Dividend Growth22.22%N/AN/AN/AN/A
Payout Ratio17.36%N/AN/AN/AN/A
Years of Consecutive Dividend Growth1 YearsN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.81%0.04%N/A0.81%0.06%
Current Ratio1.38%6.04%6.86%6.42%6.66%
Quick Ratio1.03%3.68%5.08%5.81%5.65%
Ownership Information
Institutional Ownership Percentage84.11%80.61%66.96%93.19%91.18%
Insider Ownership Percentage0.69%7.50%16.50%4.80%15.30%
Miscellaneous
Employees10,0003,3002,2001,500449
Shares Outstanding65.82 million36.58 million100.89 million63.03 million35.15 million
Next Earnings Date11/5/2021 (Estimated)10/27/2021 (Estimated)10/27/2021 (Estimated)11/4/2021 (Estimated)11/8/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableNot Optionable
SourceHeadline
A Look At The Intrinsic Value Of ShockWave Medical, Inc. (NASDAQ:SWAV)A Look At The Intrinsic Value Of ShockWave Medical, Inc. (NASDAQ:SWAV)
au.finance.yahoo.com - September 20 at 2:30 PM
ShockWave Medical (NASDAQ:SWAV) Trading Down 7.9%ShockWave Medical (NASDAQ:SWAV) Trading Down 7.9%
americanbankingnews.com - September 20 at 12:26 PM
ShockWave Medical Inc. (NASDAQ: SWAV) Slashes -1.73%: A Look At The Most Likely Path Going ForwardShockWave Medical Inc. (NASDAQ: SWAV) Slashes -1.73%: A Look At The Most Likely Path Going Forward
stocksregister.com - September 18 at 2:34 PM
Shockwave Medical Inc (SWAV): Price Now Near $217.44; Daily Chart Shows An Uptrend on 50 Day BasisShockwave Medical Inc (SWAV): Price Now Near $217.44; Daily Chart Shows An Uptrend on 50 Day Basis
etfdailynews.com - September 14 at 6:21 PM
IRadimed (NASDAQ:IRMD) versus ShockWave Medical (NASDAQ:SWAV) Financial ReviewIRadimed (NASDAQ:IRMD) versus ShockWave Medical (NASDAQ:SWAV) Financial Review
americanbankingnews.com - September 14 at 5:16 PM
ShockWave Medical (NASDAQ:SWAV)  Shares Down 3.7% ShockWave Medical (NASDAQ:SWAV) Shares Down 3.7%
americanbankingnews.com - September 9 at 12:52 PM
Why Did Shockwave Medical Stock Gain 18% in August?Why Did Shockwave Medical Stock Gain 18% in August?
finance.yahoo.com - September 7 at 6:25 PM
ShockWave Medical (NASDAQ:SWAV) Hits New 1-Year High at $230.00ShockWave Medical (NASDAQ:SWAV) Hits New 1-Year High at $230.00
americanbankingnews.com - September 7 at 10:32 AM
Is ShockWave Medical (SWAV) A Worthy Investment Choice?Is ShockWave Medical (SWAV) A Worthy Investment Choice?
finance.yahoo.com - September 6 at 4:24 PM
Shockwave Medical Inc (SWAV) CFO Dan Puckett Sold $542,325 of SharesShockwave Medical Inc (SWAV) CFO Dan Puckett Sold $542,325 of Shares
finance.yahoo.com - September 3 at 5:46 PM
ShockWave Medical, Inc. (NASDAQ:SWAV) CFO Dan Puckett Sells 2,500 SharesShockWave Medical, Inc. (NASDAQ:SWAV) CFO Dan Puckett Sells 2,500 Shares
americanbankingnews.com - September 2 at 10:14 PM
Shockwave Medical Inc (SWAV): Price Now Near $213.33; Daily Chart Shows An Uptrend on 20 Day BasisShockwave Medical Inc (SWAV): Price Now Near $213.33; Daily Chart Shows An Uptrend on 20 Day Basis
etfdailynews.com - August 31 at 9:03 PM
Unlocking Growth Opportunity In ShockWave Medical Inc. (NASDAQ: SWAV)Unlocking Growth Opportunity In ShockWave Medical Inc. (NASDAQ: SWAV)
stocksregister.com - August 28 at 4:43 PM
ShockWave Medical (NASDAQ:SWAV) Upgraded at Zacks Investment ResearchShockWave Medical (NASDAQ:SWAV) Upgraded at Zacks Investment Research
marketbeat.com - August 27 at 5:33 AM
Is Shockwave Medical (SWAV) A Good Stock To Buy Now?Is Shockwave Medical (SWAV) A Good Stock To Buy Now?
finance.yahoo.com - August 27 at 4:06 AM
Shockwave Medical to Participate in Two Upcoming Virtual Investor ConferencesShockwave Medical to Participate in Two Upcoming Virtual Investor Conferences
finance.yahoo.com - August 26 at 6:06 PM
Shockwave Medical Inc (SWAV): Price Now Near $203.13; Daily Chart Shows An Uptrend on 100 Day BasisShockwave Medical Inc (SWAV): Price Now Near $203.13; Daily Chart Shows An Uptrend on 100 Day Basis
etfdailynews.com - August 25 at 4:14 PM
This Healthcare Stock Grew Revenue by More Than 400% in the Second QuarterThis Healthcare Stock Grew Revenue by More Than 400% in the Second Quarter
finance.yahoo.com - August 25 at 8:56 AM
Shockwave Medical Inc (SWAV) President & CEO Douglas Evan Godshall Sold $8.5 million of SharesShockwave Medical Inc (SWAV) President & CEO Douglas Evan Godshall Sold $8.5 million of Shares
uk.finance.yahoo.com - August 21 at 4:40 PM
Should You Consider Investing in ShockWave Medical (SWAV)?Should You Consider Investing in ShockWave Medical (SWAV)?
finance.yahoo.com - August 18 at 6:01 PM
IBD 50 Stocks To Watch: Medical Product Pioneer Nears Buy Point After Earnings; Should You Invest?IBD 50 Stocks To Watch: Medical Product Pioneer Nears Buy Point After Earnings; Should You Invest?
finance.yahoo.com - August 18 at 6:01 PM
Noteworthy Tuesday Option Activity: SQ, SWAV, LYVNoteworthy Tuesday Option Activity: SQ, SWAV, LYV
nasdaq.com - August 17 at 4:14 PM
Forecast: Analysts Think ShockWave Medical, Inc.s (NASDAQ:SWAV) Business Prospects Have Improved DrasticallyForecast: Analysts Think ShockWave Medical, Inc.'s (NASDAQ:SWAV) Business Prospects Have Improved Drastically
nasdaq.com - August 15 at 4:17 PM
New Forecasts: Heres What Analysts Think The Future Holds For ShockWave Medical, Inc. (NASDAQ:SWAV)New Forecasts: Here's What Analysts Think The Future Holds For ShockWave Medical, Inc. (NASDAQ:SWAV)
finance.yahoo.com - August 15 at 4:17 PM
ShockWave Medical, Inc. (NASDAQ:SWAV) Reported Earnings Last Week And Analysts Are Already Upgrading Their EstimatesShockWave Medical, Inc. (NASDAQ:SWAV) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
nasdaq.com - August 12 at 3:23 PM
Here’s Why You Should Invest in ShockWave Medical (SWAV)Here’s Why You Should Invest in ShockWave Medical (SWAV)
finance.yahoo.com - August 12 at 3:23 PM
DateCompanyBrokerageAction
9/24/2021Tandem Diabetes CareSVB Leerink
Boost Price Target
9/19/2021Hill-RomMorgan Stanley
Downgrade
9/16/2021PenumbraTruist Securities
Initiated Coverage
9/15/2021PenumbraTruist
Initiated Coverage
9/8/2021Hill-RomKeyCorp
Downgrade
9/3/2021Hill-RomRobert W. Baird
Downgrade
8/10/2021Hill-RomBank of America
Downgrade
8/10/2021PenumbraCitigroup
Boost Price Target
8/10/2021PenumbraBTIG Research
Boost Price Target
8/10/2021ShockWave MedicalMorgan Stanley
Boost Price Target
8/10/2021ShockWave MedicalSVB Leerink
Boost Price Target
8/5/2021Globus MedicalMorgan Stanley
Boost Price Target
8/5/2021Globus MedicalSVB Leerink
Boost Price Target
8/5/2021Globus MedicalCredit Suisse Group
Boost Price Target
8/5/2021Globus MedicalWells Fargo & Company
Boost Price Target
8/5/2021Globus MedicalCanaccord Genuity
Boost Price Target
8/5/2021Globus MedicalNeedham & Company LLC
Boost Price Target
8/5/2021Globus MedicalCitigroup
Boost Price Target
8/5/2021Tandem Diabetes CareSVB Leerink
Boost Price Target
8/5/2021Tandem Diabetes CareOppenheimer
Boost Price Target
8/5/2021Tandem Diabetes CareCraig Hallum
Boost Price Target
8/5/2021Tandem Diabetes CareWells Fargo & Company
Boost Price Target
8/5/2021Tandem Diabetes CareRaymond James
Boost Price Target
8/2/2021Hill-RomMorgan Stanley
Boost Price Target
8/2/2021Hill-RomRobert W. Baird
Boost Price Target
8/2/2021Hill-RomKeyCorp
Boost Price Target
7/15/2021ShockWave MedicalSVB Leerink
Initiated Coverage
7/12/2021ShockWave MedicalBank of America
Downgrade
6/18/2021ShockWave MedicalWells Fargo & Company
Downgrade
6/15/2021ShockWave MedicalPiper Sandler
Boost Price Target
6/8/2021PenumbraWells Fargo & Company
Reiterated Rating
6/7/2021ShockWave MedicalWells Fargo & Company
Boost Price Target
6/4/2021PenumbraBTIG Research
Upgrade
5/24/2021Tandem Diabetes CareBarclays
Initiated Coverage
5/11/2021ShockWave MedicalMorgan Stanley
Boost Price Target
5/11/2021ShockWave MedicalCanaccord Genuity
Boost Price Target
5/11/2021ShockWave MedicalWells Fargo & Company
Boost Price Target
5/11/2021ShockWave MedicalBank of America
Upgrade
5/11/2021ShockWave MedicalPiper Sandler
Upgrade
5/6/2021Tandem Diabetes CareOppenheimer
Boost Price Target
5/6/2021Tandem Diabetes CareSVB Leerink
Boost Price Target
5/5/2021PenumbraCitigroup
Boost Price Target
5/5/2021PenumbraWells Fargo & Company
Boost Price Target
5/5/2021PenumbraCanaccord Genuity
Boost Price Target
5/5/2021Globus MedicalCitigroup
Boost Price Target
5/5/2021Globus MedicalCanaccord Genuity
Boost Price Target
5/5/2021Globus MedicalBTIG Research
Boost Price Target
5/5/2021Globus MedicalMorgan Stanley
Boost Price Target
5/5/2021Globus MedicalWells Fargo & Company
Boost Price Target
5/5/2021Globus MedicalSVB Leerink
Boost Price Target
5/5/2021Globus MedicalNeedham & Company LLC
Boost Price Target
5/3/2021Hill-RomRaymond James
Boost Price Target
5/3/2021Hill-RomRobert W. Baird
Boost Price Target
4/28/2021ShockWave MedicalOppenheimer
Reiterated Rating
4/19/2021ShockWave MedicalMorgan Stanley
Boost Price Target
4/1/2021Tandem Diabetes CareSVB Leerink
Lower Price Target
3/31/2021Tandem Diabetes CareOppenheimer
Reiterated Rating
3/31/2021ShockWave MedicalCanaccord Genuity
Boost Price Target
2/25/2021Globus MedicalMorgan Stanley
Boost Price Target
2/25/2021Tandem Diabetes CareLake Street Capital
Boost Price Target
2/25/2021ShockWave MedicalMorgan Stanley
Boost Price Target
2/24/2021PenumbraCitigroup
Boost Price Target
2/24/2021PenumbraCanaccord Genuity
Boost Price Target
2/24/2021PenumbraWells Fargo & Company
Boost Price Target
2/18/2021Globus MedicalCitigroup
Boost Price Target
2/18/2021Globus MedicalNeedham & Company LLC
Boost Price Target
2/18/2021Globus MedicalBTIG Research
Boost Price Target
2/18/2021ShockWave MedicalPiper Sandler
Boost Price Target
2/16/2021Hill-RomRaymond James
Boost Price Target
2/8/2021Hill-RomRaymond James
Boost Price Target
2/8/2021Hill-RomMorgan Stanley
Boost Price Target
2/8/2021Hill-RomRobert W. Baird
Boost Price Target
2/2/2021ShockWave MedicalCanaccord Genuity
Boost Price Target
1/29/2021Globus MedicalPiper Sandler
Boost Price Target
1/20/2021ShockWave MedicalPiper Sandler
Downgrade
1/12/2021ShockWave MedicalWells Fargo & Company
Boost Price Target
1/8/2021Globus MedicalCredit Suisse Group
Boost Price Target
12/16/2020PenumbraWells Fargo & Company
Lower Price Target
12/16/2020PenumbraCanaccord Genuity
Lower Price Target
12/16/2020PenumbraBTIG Research
Downgrade
12/15/2020Hill-RomMorgan Stanley
Boost Price Target
12/15/2020Globus MedicalMorgan Stanley
Boost Price Target
12/15/2020Tandem Diabetes CareWells Fargo & Company
Downgrade
12/15/2020ShockWave MedicalMorgan Stanley
Boost Price Target
12/8/2020Globus MedicalSmith Barney Citigroup
Initiated Coverage
12/1/2020ShockWave MedicalBank of America
Downgrade
11/11/2020ShockWave MedicalMorgan Stanley
Boost Price Target
11/10/2020ShockWave MedicalWells Fargo & Company
Boost Price Target
11/10/2020ShockWave MedicalPiper Sandler
Boost Price Target
11/9/2020Hill-RomRaymond James
Boost Price Target
11/6/2020Tandem Diabetes CareRaymond James
Boost Price Target
11/6/2020Tandem Diabetes CareSVB Leerink
Boost Price Target
11/6/2020Tandem Diabetes CarePiper Sandler
Boost Price Target
11/4/2020Hill-RomNeedham & Company LLC
Downgrade
10/29/2020PenumbraSmith Barney Citigroup
Boost Price Target
10/29/2020PenumbraWells Fargo & Company
Boost Price Target
10/29/2020PenumbraCanaccord Genuity
Boost Price Target
10/29/2020PenumbraBTIG Research
Boost Price Target
10/29/2020Globus MedicalCredit Suisse Group
Boost Price Target
10/19/2020Globus MedicalStifel Nicolaus
Initiated Coverage
10/12/2020Hill-RomRaymond James
Lower Price Target
10/7/2020PenumbraCanaccord Genuity
Reiterated Rating
10/1/2020Hill-RomKeyCorp
Lower Price Target
9/29/2020Hill-RomNeedham & Company LLC
Lower Price Target
9/29/2020PenumbraBTIG Research
Initiated Coverage
9/21/2020Hill-RomMorgan Stanley
Lower Price Target
9/21/2020Tandem Diabetes CareOppenheimer
Reiterated Rating
9/16/2020Hill-RomRaymond James
Reiterated Rating
9/8/2020PenumbraBank of America
Downgrade
9/1/2020Hill-RomRobert W. Baird
Initiated Coverage
8/28/2020Tandem Diabetes CareSVB Leerink
Boost Price Target
8/20/2020Tandem Diabetes CareWells Fargo & Company
Initiated Coverage
8/6/2020Globus MedicalOppenheimer
Initiated Coverage
8/4/2020PenumbraCanaccord Genuity
Boost Price Target
8/4/2020PenumbraWells Fargo & Company
Boost Price Target
8/4/2020PenumbraCitigroup
Boost Price Target
8/3/2020Hill-RomMorgan Stanley
Lower Price Target
8/3/2020Hill-RomRaymond James
Lower Price Target
8/3/2020Hill-RomKeyCorp
Lower Price Target
7/31/2020Tandem Diabetes CareRaymond James
Boost Price Target
7/31/2020Tandem Diabetes CareCraig Hallum
Boost Price Target
7/31/2020Tandem Diabetes CareLake Street Capital
Boost Price Target
7/31/2020Tandem Diabetes CareSVB Leerink
Boost Price Target
7/31/2020Tandem Diabetes CareGuggenheim
Upgrade
7/31/2020Tandem Diabetes CarePiper Sandler
Boost Price Target
(Data available from 9/25/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.